The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Safeway Raises $16.1 Million in October for Breast Cancer Research

Monday, November 08, 2010

Safeway Raises $16.1 Million in October for Breast Cancer Research13:52 EST Monday, November 08, 2010 PLEASANTON, Calif. (Business Wire) -- Safeway Inc. (NYSE: SWY), one of the nation's largest supporters of cancer research and treatment, today announced its stores raised $16.1 million in October to combat breast cancer, the most common form of cancer for women. Funds donated at checkout by Safeway customers throughout North America support three areas of focus: research, treatment and early detection. “We are grateful and humbled by the extraordinary outpouring of support for a cause that impacts so many women and families,” said Larree Renda, Safeway Executive Vice President and Chair of The Safeway Foundation. “Even in a difficult economic climate, our customers recognize the importance of continuing the search for more effective treatments and an ultimate cure for breast cancer.” During the last decade Safeway and its 1,700-plus stores — including Vons, Pavilions, Dominick's, Tom Thumb, Randalls, Genuardi's, Carrs and Pak ‘N Save — have raised and donated more than $94 million during the annual October Breast Cancer Awareness campaign. The largest share of the funds continue to be dedicated to a range of ambitious research projects as well as other programs that elevate the level of care patients receive and programs focused on early detection. “Safeway's efforts are making a big impact on the science of finding a cure for breast cancer,” said Dr. Laura Esserman, Professor of Surgery and Radiology, and Director, Carol Franc Buck Breast Care Center at the University of California, San Francisco. “Safeway grants are, in fact, funding ground breaking research that isadvancing our ability to identify the right treatments for the right patients, and to do it now. This will save lives.” Grants with potential for having the broadest impact are those the company is sending to research projects at North America's most respected cancer centers and hospitals. This research includes the I-SPY TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis) which is now in its second phase. I-SPY doctors use data from each patient as they go through the study to, in turn, treat other patients, a process that quickly creates a set of approved protocols, rather than waiting months or years for a more formal study to recommend the exact same course of action. Another benefit is that treatments are personalized for each patient based on bio-markers, which tell doctors about each patient's unique tumor molecular make-up. In this next phase, as many as 12 new experimental drugs will be tested in combination with standard therapy prior to surgery. Safeway has also partnered with hospitals and cancer centers to increase access to mammograms by supporting mobile mammography units, “mammovans” in various areas throughout the country. Grants from the annual Breast Cancer Awareness campaign help keep six such state-of-the-art mobile breast cancer screening centers on the road. During October these mammovans were deployed to some of the most remote and underserved areas of their service geographies to provide mammograms to women who would otherwise lack access to this important screening. Similar grants were used to purchase multiple mammovans and continue to finance the operation of these units through partnerships with the Rose Foundation of Houston, Texas; the Nevada Health Centers Inc.; St. Joseph's Medical Center in Stockton, Calif; Fred Hutchinson Cancer Center; the Seattle Cancer Care Alliance; Providence Alaska Medical Center; Exempla- St. Joseph's Hospital of Denver, Colorado; and George Washington University Hospital of Washington, D.C. Safeway's Breast Cancer Awareness fundraiser is the second of two annual cancer campaigns. Each June Safeway raises money to combat prostate cancer, one of the most prevalent forms of cancer in men. To date, the company has raised more than $160 million for cancer causes. However, cancer research is just one of the many important causes that the company supports each year. Safeway contributes to a broad range of charitable and community programs and in 2009 donated more than $250 million to education, hunger relief, health and human services and programs focused on assisting people with disabilities. About Safeway Safeway Inc. is a Fortune 100 company and one of the largest food and drug retailers in North America, based on sales. The company operates 1,712 stores in the United States and western Canada and had annual sales of $40.8 billion in 2009. The company's common stock is traded on the New York Stock Exchange under the symbol SWY. Safeway Inc.Teena Massingill,